Merit Medical Systems Gross Profit 2010-2023 | MMSI
Merit Medical Systems gross profit from 2010 to 2023. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Merit Medical Systems Annual Gross Profit (Millions of US $) |
2023 |
$584 |
2022 |
$519 |
2021 |
$485 |
2020 |
$401 |
2019 |
$432 |
2018 |
$395 |
2017 |
$326 |
2016 |
$265 |
2015 |
$236 |
2014 |
$225 |
2013 |
$194 |
2012 |
$182 |
2011 |
$165 |
2010 |
$128 |
2009 |
$109 |
Merit Medical Systems Quarterly Gross Profit (Millions of US $) |
2023-12-31 |
$151 |
2023-09-30 |
$142 |
2023-06-30 |
$153 |
2023-03-31 |
$138 |
2022-12-31 |
$135 |
2022-09-30 |
$129 |
2022-06-30 |
$135 |
2022-03-31 |
$121 |
2021-12-31 |
$129 |
2021-09-30 |
$120 |
2021-06-30 |
$124 |
2021-03-31 |
$112 |
2020-12-31 |
$111 |
2020-09-30 |
$102 |
2020-06-30 |
$84 |
2020-03-31 |
$104 |
2019-12-31 |
$112 |
2019-09-30 |
$104 |
2019-06-30 |
$112 |
2019-03-31 |
$105 |
2018-12-31 |
$105 |
2018-09-30 |
$102 |
2018-06-30 |
$100 |
2018-03-31 |
$88 |
2017-12-31 |
$86 |
2017-09-30 |
$81 |
2017-06-30 |
$84 |
2017-03-31 |
$76 |
2016-12-31 |
$70 |
2016-09-30 |
$68 |
2016-06-30 |
$67 |
2016-03-31 |
$60 |
2015-12-31 |
$60 |
2015-09-30 |
$59 |
2015-06-30 |
$61 |
2015-03-31 |
$55 |
2014-12-31 |
$60 |
2014-09-30 |
$57 |
2014-06-30 |
$56 |
2014-03-31 |
$52 |
2013-12-31 |
$53 |
2013-09-30 |
$51 |
2013-06-30 |
$47 |
2013-03-31 |
$43 |
2012-12-31 |
$45 |
2012-09-30 |
$45 |
2012-06-30 |
$47 |
2012-03-31 |
$44 |
2011-12-31 |
$42 |
2011-09-30 |
$41 |
2011-06-30 |
$42 |
2011-03-31 |
$40 |
2010-12-31 |
$36 |
2010-09-30 |
$31 |
2010-06-30 |
$32 |
2010-03-31 |
$28 |
2009-12-31 |
$27 |
2009-09-30 |
$29 |
2009-06-30 |
$28 |
2009-03-31 |
$25 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$4.122B |
$1.257B |
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
|